Investigation of Dextran-Coated Superparamagnetic Nanoparticles for Targeted Vinblastine Controlled Release, Delivery, Apoptosis Induction, and Gene Expression in Pancreatic Cancer Cells.
Apoptosis
/ drug effects
Cell Line, Tumor
Cell Survival
/ drug effects
Delayed-Action Preparations
/ chemistry
Dextrans
/ chemistry
Folic Acid
/ chemistry
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
Magnetite Nanoparticles
/ chemistry
Neoplasm Proteins
/ genetics
Pancreatic Neoplasms
/ drug therapy
Vinblastine
/ chemistry
apoptotic cells
dextran
folic acid
gene expression
nanostructure
pancreatic cancer
superparamagnetic iron oxide nanoparticles
vinblastine
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
received:
25
09
2020
revised:
10
10
2020
accepted:
12
10
2020
entrez:
20
10
2020
pubmed:
21
10
2020
medline:
27
3
2021
Statut:
epublish
Résumé
In the current study, the surface of superparamagnetic iron oxide (SPION) was coated with dextran (DEX), and conjugated with folic acid (FA), to enhance the targeted delivery and uptake of vinblastine (VBL) in PANC-1 pancreatic cancer cells. Numerous analyses were performed to validate the prepared FA-DEX-VBL-SPION, such as field emission scanning transmission electron microscopy, high-resolution transmission electron microscopy, dynamic light scattering (DLS), Zeta Potential, Fourier transform infrared spectroscopy, and vibrating sample magnetometry (VSM). The delivery system capacity was evaluated by loading and release experiments. Moreover, in vitro biological studies, including a cytotoxicity study, cellular uptake assessment, apoptosis analysis, and real-time PCR, were carried out. The results revealed that the obtained nanocarrier was spherical with a suitable dispersion and without visible aggregation. Its average size, polydispersity, and zeta were 74 ± 13 nm, 0.080, and -45 mV, respectively. This dual functional nanocarrier also exhibited low cytotoxicity and a high apoptosis induction potential for successful VBL co-delivery. Real-time quantitative PCR analysis demonstrated the activation of
Identifiants
pubmed: 33076247
pii: molecules25204721
doi: 10.3390/molecules25204721
pmc: PMC7587551
pii:
doi:
Substances chimiques
Delayed-Action Preparations
0
Dextrans
0
Magnetite Nanoparticles
0
Neoplasm Proteins
0
Vinblastine
5V9KLZ54CY
Folic Acid
935E97BOY8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Technology- Applied Science Department and Deanship of Scientific Research at King Saud University
ID : RGP-1435-086
Références
J Exp Clin Cancer Res. 2017 Sep 2;36(1):115
pubmed: 28865485
Front Oncol. 2019 Feb 13;9:59
pubmed: 30815389
J Biomed Nanotechnol. 2015 Nov;11(11):1859-98
pubmed: 26554150
Asian J Pharm Sci. 2017 Mar;12(2):172-178
pubmed: 32104327
Expert Opin Drug Deliv. 2018 May;15(5):523-540
pubmed: 29543082
Transl Gastroenterol Hepatol. 2018 Nov 07;3:89
pubmed: 30603725
Drug Des Devel Ther. 2019 Oct 30;13:3753-3772
pubmed: 31802849
Bioimpacts. 2015;5(3):141-50
pubmed: 26457252
Phytomedicine. 2015 Dec 15;22(14):1232-7
pubmed: 26655405
Oncol Lett. 2015 Aug;10(2):595-599
pubmed: 26622539
Gels. 2020 Feb 04;6(1):
pubmed: 32033057
Exp Ther Med. 2020 Mar;19(3):2008-2018
pubmed: 32104260
Int J Urol. 2018 Aug;25(8):730-736
pubmed: 30016829
Int J Clin Exp Med. 2015 Oct 15;8(10):19670-81
pubmed: 26770631
J Nanobiotechnology. 2018 Sep 19;16(1):71
pubmed: 30231877
Cancers (Basel). 2019 Jan 15;11(1):
pubmed: 30650643
Sci Rep. 2020 Jul 8;10(1):11239
pubmed: 32641693
Neurogenetics. 2007 Apr;8(2):121-30
pubmed: 17216419
J Exp Clin Cancer Res. 2011 Sep 26;30:87
pubmed: 21943236
J Mater Sci Mater Med. 2017 Apr;28(4):55
pubmed: 28210967
Int J Nanomedicine. 2018 Mar 28;13:1899-1915
pubmed: 29636608
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S125-S132
pubmed: 30033772
Biomacromolecules. 2014 May 12;15(5):1560-7
pubmed: 24716601
Curr Med Chem. 2018;25(14):1650-1662
pubmed: 28464783
Invest New Drugs. 2018 Apr;36(2):323-331
pubmed: 28852916
PLoS One. 2018 Apr 3;13(4):e0195401
pubmed: 29614107
Pharmaceutics. 2019 May 03;11(5):
pubmed: 31058849
Carbohydr Polym. 2014 Feb 15;102:103-9
pubmed: 24507261
Drug Deliv. 2019 Dec;26(1):252-261
pubmed: 30857442
AIDS. 2013 Mar 27;27(6):1033-5
pubmed: 23698067
Sci Rep. 2019 Mar 19;9(1):4868
pubmed: 30890736
J Biomed Mater Res B Appl Biomater. 2016 May;104(4):808-16
pubmed: 26996397